Table 1.
Baseline clinicopathological characteristics of patients with bladder cancer
| Characteristics | Total n = 516 |
|---|---|
| Age, years, median (IQR) | 66 (35–91) |
| Female sex, n (%) | 80 (15.5%) |
| Histology type, n (%) | |
| UC | 488 (94.6%) |
| NUC | 28 (5.4%) |
| Pathological grade, n (%) | |
| 2 | 131 (25.4%) |
| 3 | 385 (74.6%) |
| Smoking history | 161 (31.2%) |
| Diabetes Mellitus | 56 (10.9%) |
| Hypertension | 149 (28.9%) |
| Heart disease | 55 (10.7%) |
| Cerebrovascular disease | 17 (3.3%) |
| pT stage, n (%) | |
| 1 | 162 (31.4%) |
| 2 | 161 (31.2%) |
| 3 | 105 (20.3%) |
| 4 | 88 (17.1%) |
| pN status, n (%) | |
| negative | 81 (15.7%) |
| positive | 435 (84.3%) |
| ASA grade, n (%) | |
| 1&2 | 436 (84.5%) |
| 3&4 | 80 (15.5%) |
| Surgery style | |
| open | 409 (79.3%) |
| laparoscopic | 107 (20.7%) |
| Postoperative complications | |
| present | 73 (8.3%) |
| absent | 443 (91.7%) |
| Anemia | |
| present | 144 (27.9%) |
| absent | 372 (72.1%) |
| Hypoalbuminemia | |
| present | 74 (14.3%) |
| absent | 442 (85.7%) |
| NLR, median (IQR) | 2.34 (1.74–3.49) |
| PLR, median (IQR) | 133.8 (98.22–180.22) |
| LMR, median (IQR) | 4.37 (3.30–5.72) |
| PNI, median (IQR) | 47.8 (44.66–51.58) |
UC urothelial carcinoma, NUC non-urothelial carcinoma, ASA American Society of Anesthesiologists, PNI prognostic nutritional index, NLR neutrophil-lymphocyte ratio, PLR platelet-lymphocyte ratio, LMR lymphocyte-monocyte ratio, IQR, interquartile range